Sagerer, Elena
Wirner, Corinna
Schoser, Benedikt http://orcid.org/0000-0002-2757-8131
Wenninger, Stephan http://orcid.org/0000-0001-8407-3642
Funding for this research was provided by:
DGM: Deutsche Gesellschaft für Muskelkranke
Universitätsklinik München
Article History
Received: 13 June 2022
Revised: 19 August 2022
Accepted: 21 August 2022
First Online: 29 August 2022
Declarations
:
: All authors report no disclosures regarding this study. Outside of this context, SW has received research grant by the DGM—Deutsche Gesellschaft für Muskelkranke e.V. He has served on advisory boards for Alexion Pharma, CSL Behring and Sanofi Genzyme GmbH. He received funding for travel or speaker Honoraria from Sanofi-Aventis Germany GmbH; SH Glykogenose Gesellschaft; AbbVie Germany GmbH; Recordati Pharma GmbH; CSLBehring GmbH; Alexion Pharma GmbH; Desitin Germany; Akcea GmbH. Outside of this context, BS has served on advisory boards for Alexion, Argenex, Amicus, Astellas, Spark, and Sanofi; he has undertaken contracted unrestricted research for Sanofi and Amicus; and has received honoraria from Kedrion. The other authors have no conflicts of interest to declare.
: The study was approved by the ethics committee of the LMU Klinikum, Project No. 20–0980, and the protocol was registered on a public clinical trials registry (ClinicalTrials.gov Identifier NCT04907162).